According to the latest stats on the CBioPortal of Cancer Genetics (https://www.cbioportal.org/), PIK3CA expressed 35% of cervical cancer, 38% in cervical cancer squamous cell carcinoma, and 39% in cervical adenocarcinoma. This evidence concerns the gene PIK3CA and cervical adenocarcinoma.